Martin Shkreli became America’s most hated man even though most of us had never heard of him before. The 32-year-old chief executive of Turing Pharmaceuticals acquired the rights to Daraprim. Developed in the 1950s, this drug is the best treatment for a relatively rare parasitic infection called toxoplasmosis. He then raised the price overnight to $750 a pill from about $13.50.